^
CANCER:
Mast Cell Leukemia
TMB-L
|
Mast Cell Leukemia
|
TMB-L
|
Mast Cell Leukemia
|
T-lymphocyte cell therapy Sensitive: C3 – Early Trials
|
T-lymphocyte cell therapy Sensitive: C3 – Early Trials
|
LDH-L
|
Mast Cell Leukemia
|
LDH-L
|
Mast Cell Leukemia
|
T-lymphocyte cell therapy Sensitive: C3 – Early Trials
|
T-lymphocyte cell therapy Sensitive: C3 – Early Trials
|
KIT D816V
|
Mast Cell Leukemia
|
KIT D816V
|
Mast Cell Leukemia
|
abemaciclib Sensitive: D – Preclinical
|
abemaciclib Sensitive: D – Preclinical
|
KIT D816V
|
Mast Cell Leukemia
|
KIT D816V
|
Mast Cell Leukemia
|
palbociclib Sensitive: D – Preclinical
|
palbociclib Sensitive: D – Preclinical
|
KIT D816V
|
Mast Cell Leukemia
|
KIT D816V
|
Mast Cell Leukemia
|
ribociclib Sensitive: D – Preclinical
|
ribociclib Sensitive: D – Preclinical
|
